Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer von Ward, M J, Thirdborough, S M, Mellows, T, Riley, C, Harris, S, Suchak, K, Webb, A, Hampton, C, Patel, N N, Randall, C J, Cox, H J, Jogai, S, Primrose, J, Piper, K, Ottensmeier, C H, King, E V, Thomas, G J

Volltext

The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery von Jack, S, West, M.A, Raw, D, Marwood, S, Ambler, G, Cope, T.M, Shrotri, M, Sturgess, R.P, Calverley, P.M.A, Ottensmeier, C.H, Grocott, M.P.W

Volltext

DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma von Gupta, A., Love, S., Schuh, A., Shanyinde, M., Larkin, J.M., Plummer, R., Nathan, P.D., Danson, S., Ottensmeier, C.H., Lorigan, P., Collins, L., Wise, A., Asher, R., Lisle, R., Middleton, M.R.

Volltext

Uveal Melanoma UK National Guidelines von Nathan, P, Cohen, V, Coupland, S, Curtis, K, Damato, B, Evans, J, Fenwick, S, Kirkpatrick, L, Li, O, Marshall, E, McGuirk, K, Ottensmeier, C, Pearce, N, Salvi, S, Stedman, B, Szlosarek, P, Turnbull, N

Volltext

FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role von Bullock, M D, Bruce, A, Sreekumar, R, Curtis, N, Cheung, T, Reading, I, Primrose, J N, Ottensmeier, C, Packham, G K, Thomas, G, Mirnezami, A H

Volltext

Response definition criteria for ELISPOT assays revisited von Moodie, Z, Price, L, Gouttefangeas, C, Mander, A, Janetzki, S, Löwer, M, Welters, M. J. P, Ottensmeier, C, van der Burg, S. H, Britten, Cedrik M

Volltext

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab von Hardy-Werbin, M., Arpí, O., Taus, A., Rocha, P., Joseph-Pietras, D., Nolan, L., Danson, S., Griffiths, R., Lopez-Botet, M., Rovira, A., Albanell, J., Ottensmeier, C. H., Arriola, E.

Volltext

T Cell Assays and MIATA: The Essential Minimum for Maximum Impact von Britten, C.M., Janetzki, S., Butterfield, L.H., Ferrari, G., Gouttefangeas, C., Huber, C., Kalos, M., Levitsky, H.I., Maecker, H.T., Melief, C.J.M., O’Donnell-Tormey, J., Odunsi, K., Old, L.J., Ottenhoff, T.H.M., Ottensmeier, C., Pawelec, G., Roederer, M., Roep, B.O., Romero, P., van der Burg, S.H., Walter, S., Hoos, A., Davis, M.M.

Volltext

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma von McCormick Matthews, L H, Noble, F, Tod, J, Jaynes, E, Harris, S, Primrose, J N, Ottensmeier, C, Thomas, G J, Underwood, T J

Volltext

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial von Corrie, P.G., Marshall, A., Nathan, P.D., Lorigan, P., Gore, M., Tahir, S., Faust, G., Kelly, C.G., Marples, M., Danson, S.J., Marshall, E., Houston, S.J., Board, R.E., Waterston, A.M., Nobes, J.P., Harries, M., Kumar, S., Goodman, A., Dalgleish, A., Martin-Clavijo, A., Westwell, S., Casasola, R., Chao, D., Maraveyas, A., Patel, P.M., Ottensmeier, C.H., Farrugia, D., Humphreys, A., Eccles, B., Young, G., Barker, E.O., Harman, C., Weiss, M., Myers, K.A., Chhabra, A., Rodwell, S.H., Dunn, J.A., Middleton, M.R.

Volltext

PS01.11 Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial von Fennell, D., Ottensmeier, C., Califano, R., Hanna, G., Ewings, S., Hill, K., Wilding, S., Danson, S., Nye, M., Steele, N., Johnson, L., Lord, J., Middleton, C., Marwood, E., Szlosarek, P., Chan, S., Gaba, A., Darlison, L., Wells-Jordan, P., Richards, C., Poile, C., Lester, J.

Volltext

Immunotherapy in the immunodeficient: A treatment paradox? von Campbell, N.J., Longley, J., Pascalis, A., Bennett, J., Remer, M., Stone, R., Muller, D., Karydis, I., Donnelly, O., Wheater, M., Ottensmeier, C.

Volltext

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma von Matthews, Lh McCormick, Noble, F, Tod, J, Jaynes, E, Harris, S, Primrose, J N, Ottensmeier, C, Thomas, G J, Underwood, T J

Volltext

The adaptive immune response to colorectal cancer: From the laboratory to clinical practice von Curtis, N.J, Primrose, J.N, Thomas, G.J, Mirnezami, A.H, Ottensmeier, C.H

Volltext

Melanoma sentinel node biopsy and prediction models for relapse and overall survival von Mitra, A, Conway, C, Walker, C, Cook, M, Powell, B, Lobo, S, Chan, M, Kissin, M, Layer, G, Smallwood, J, Ottensmeier, C, Stanley, P, Peach, H, Chong, H, Elliott, F, Iles, M M, Nsengimana, J, Barrett, J H, Bishop, D T, Newton-Bishop, J A

Volltext

30 Afatanib use in non-small cell cancer patients whose tumours have been previously sensitive to EGFR inhibitors: the UK Named Patient Use experience von Khan, F, Ottensmeier, C, Popat, S, Danson, S.J

Volltext

Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: The United Kingdom Named Patient Programme von Khan, F, Ottensmeier, C, Popat, S, Dua, D, Dorey, N, Ellis, S, Szabo, M, Upadhyay, S, Califano, R, Chan, S, Lee, L, Ali, C.W, Nicolson, M, Bates, A.T, Button, M, Chaudhuri, A, Mulvenna, P, Shaw, H.M, Danson, S.J

Volltext

26 Treatment and outcome in epidermal growth factor receptor mutant non-small cell lung cancer: A retrospective audit across four NHS trusts von Killick, E, Bennett, J, Bates, A, Bhatnagar, A, Fenton, P, Ottensmeier, C, Geldart, T, Cave, J, Nolan, L

Volltext

Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program von Mander, A, Gouttefangeas, C, Ottensmeier, C, Welters, M. J. P, Low, L, van der Burg, S. H, Britten, C. M

Volltext

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma von Weber, Jeffrey, Mandala, Mario, Del Vecchio, Michele, Gogas, Helen J, Arance, Ana M, Cowey, C. Lance, Dalle, Stéphane, Schenker, Michael, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Grob, Jean-Jacques, Butler, Marcus O, Middleton, Mark R, Maio, Michele, Atkinson, Victoria, Queirolo, Paola, Gonzalez, Rene, Kudchadkar, Ragini R, Smylie, Michael, Meyer, Nicolas, Mortier, Laurent, Atkins, Michael B, Long, Georgina V, Bhatia, Shailender, Lebbé, Celeste, Rutkowski, Piotr, Yokota, Kenji, Yamazaki, Naoya, Kim, Tae M, de Pril, Veerle, Sabater, Javier, Qureshi, Anila, Larkin, James, Ascierto, Paolo A

Volltext